Literature DB >> 16113452

Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery.

Joachim Heyder1.   

Abstract

Particle behavior in the human respiratory tract is well understood and can be used to (1) estimate particle deposition in all regions of the respiratory tract for any aerosol respired at any pattern, and (2) optimize targeting of all regions of the respiratory tract in respiratory drug delivery. Extrathoracic and alveolar regions can effectively be targeted with mono- and polydisperse aerosols respired steadily. Effective targeting of the bronchial region can only be achieved with bolus inhalations. When particles are suspended in a gas heavier than air, targeting the alveolar region can be enhanced.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16113452     DOI: 10.1513/pats.200409-046TA

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  99 in total

1.  Magnetized aerosols comprising superparamagnetic iron oxide nanoparticles improve targeted drug and gene delivery to the lung.

Authors:  Guenther Hasenpusch; Johannes Geiger; Kai Wagner; Olga Mykhaylyk; Frank Wiekhorst; Lutz Trahms; Alexandra Heidsieck; Bernhard Gleich; Christian Bergemann; Manish K Aneja; Carsten Rudolph
Journal:  Pharm Res       Date:  2012-01-21       Impact factor: 4.200

2.  An asymptotic model of particle deposition at an airway bifurcation.

Authors:  Jennifer R Zierenberg; David Halpern; Marcel Filoche; Bernard Sapoval; James B Grotberg
Journal:  Math Med Biol       Date:  2012-02-29       Impact factor: 1.854

3.  Mucosal production of uric acid by airway epithelial cells contributes to particulate matter-induced allergic sensitization.

Authors:  M J Gold; P R Hiebert; H Y Park; D Stefanowicz; A Le; M R Starkey; A Deane; A C Brown; G Liu; J C Horvat; Z A Ibrahim; M B Sukkar; P M Hansbro; C Carlsten; S VanEeden; D D Sin; K M McNagny; D A Knight; J A Hirota
Journal:  Mucosal Immunol       Date:  2015-10-28       Impact factor: 7.313

4.  Phospholipid composition modulates carbon nanodiamond-induced alterations in phospholipid domain formation.

Authors:  Aishik Chakraborty; Nicolas J Mucci; Ming Li Tan; Ashleigh Steckley; Ti Zhang; M Laird Forrest; Prajnaparamita Dhar
Journal:  Langmuir       Date:  2015-04-28       Impact factor: 3.882

5.  Behavior of submicrometer particles in periodic alveolar airflows.

Authors:  G Balik; A H Reis; M Aydin; A F Miguel
Journal:  Eur J Appl Physiol       Date:  2007-12-13       Impact factor: 3.078

6.  Nanoparticle deposition onto biofilms.

Authors:  J K Miller; R Neubig; C B Clemons; K L Kreider; J P Wilber; G W Young; A J Ditto; Y H Yun; A Milsted; H T Badawy; M J Panzner; W J Youngs; C L Cannon
Journal:  Ann Biomed Eng       Date:  2012-08-10       Impact factor: 3.934

7.  An investigation into the effect of fine lactose particles on the fluidization behaviour and aerosolization performance of carrier-based dry powder inhaler formulations.

Authors:  Hanne Kinnunen; Gerald Hebbink; Harry Peters; Jagdeep Shur; Robert Price
Journal:  AAPS PharmSciTech       Date:  2014-04-23       Impact factor: 3.246

Review 8.  Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review.

Authors:  M C Gaspar; W Couet; J-C Olivier; A A C C Pais; J J S Sousa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-26       Impact factor: 3.267

9.  Detection of plant DNA in the bronchoalveolar lavage of patients with ventilator-associated pneumonia.

Authors:  Sabri Bousbia; Laurent Papazian; Bernard La Scola; Didier Raoult
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

10.  Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals.

Authors:  Dana Willner; Mike Furlan; Matthew Haynes; Robert Schmieder; Florent E Angly; Joas Silva; Sassan Tammadoni; Bahador Nosrat; Douglas Conrad; Forest Rohwer
Journal:  PLoS One       Date:  2009-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.